Pharvaris N.V. Research and Development Expense
Pharvaris N.V. (PHVS) reported Research and Development Expense of EUR 124.48 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-02.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ResearchAndDevelopmentExpense · last filed 2026-04-02
- Pharvaris N.V. research and development expense for the quarter ending 2025-06-30 was 29.61M EUR, a 28.35% increase year-over-year.
- Pharvaris N.V. research and development expense for the quarter ending 2024-06-30 was 23.07M EUR, a 57.12% increase year-over-year.
- Pharvaris N.V. research and development expense for the quarter ending 2023-06-30 was 14.68M EUR, a 7.00% increase year-over-year.
- Pharvaris N.V. research and development expense for the quarter ending 2022-06-30 was 13.72M EUR, a 70.23% increase year-over-year.
| Period end | Research And Development Expense 3 month | Research And Development Expense 6 month | Research And Development Expense 12 month |
|---|---|---|---|
| 2025-12-31 | 124.48M EUR 20-F · filed 2026-04-02 | ||
| 2025-06-30 | 29.61M EUR 6-K · filed 2025-08-12 | 60.52M EUR 6-K · filed 2025-08-12 | |
| 2024-12-31 | 98.56M EUR 20-F · filed 2026-04-02 | ||
| 2024-06-30 | 23.07M EUR 6-K · filed 2025-08-12 | 41.58M EUR 6-K · filed 2025-08-12 | |
| 2023-12-31 | 65.58M EUR 20-F · filed 2026-04-02 | ||
| 2023-06-30 | 14.68M EUR 6-K · filed 2024-08-14 | 28.43M EUR 6-K · filed 2024-08-14 | |
| 2022-12-31 | 57.38M EUR 20-F · filed 2025-04-07 | ||
| 2022-06-30 | 13.72M EUR 6-K · filed 2023-08-07 | 27.24M EUR 6-K · filed 2023-08-07 | |
| 2021-12-31 | 35.79M EUR 20-F · filed 2024-04-10 | ||
| 2021-06-30 | 8.06M EUR 6-K · filed 2022-09-12 | 16.13M EUR 6-K · filed 2022-09-12 | |
| 2020-12-31 | 19.51M EUR 20-F · filed 2023-04-05 | ||
| 2019-12-31 | 5.68M EUR 20-F · filed 2022-03-29 | ||
| 2018-12-31 | 3.65M EUR 20-F · filed 2021-04-29 |